Dentons advised Polish Enterprise Fund VII (PEF VII), a private equity fund managed by Enterprise Investors (EI), one of the largest private equity and venture capital firms in CEE, on the sale of a 100 percent stake in Scitec Nutrition, a leading European sports nutrition producer. Ascendis Health, a South African publicity listed health and care brands company, purchased the stake for €170 million.

This transaction involved cross-border representation for EI in various European jurisdictions as well as South Africa. The team also represented EI during its original investment in Scitec in 2012.

“Dentons is proud to have advised our long-term client Enterprise Investors in this significant transaction,” commented Dentons Partner Edward Keller, who led the transaction. “Our sustained work for one of the leading private equity players in the region is a strong endorsement of our trusted advisor status in this sector. This transaction was especially important to us, as it brings our representation full circle, having represented Enterprise Investors at the time of its initial investment in Scitec at the end of 2012. Such major mandates showcase our capabilities in cross-border M&A support, as well as our contribution to the success of international businesses.”

Robert Manz, Managing Partner at Enterprise Investors, said: “The team at Dentons delivered a high quality, full service legal solution in multiple markets, to assist us in this significant transaction. We were delighted with the cooperation with Edward Keller and his team.”

The Dentons team on the deal was led by Partner Edward Keller, based in Europe.